Recombinant Influenza Vaccine
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Recombinant Influenza Vaccine, covering 2015-03-06 to 2026-07-30. Get the full timeline:
Most recent: Clinical Trial Results: Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years [Phase 4]